Mitochondrial Dysfunction and Nanotherapeutics

<p><U>Part I - Mitochondrial Dysfunction</U> </p> <p>1. Mitochondrial dysfunction and affective disorders: Focus on diet, exercise, and aging </p> <p>2. Mitochondrial dysfunction in inborn errors of metabolism </p> <p>3. Impaired mitochondrial dynamics in disease </p> <p>4. Mitochondrial dysfunction in metabolic disorders</p> <p>5. Mitochondrial dysfunction and autophagy in neurodegenerationin neurodegeneration </p> <p>6. Mitochondrial dysfunction in sepsis </p> <p>7. Drug or toxin induced mitochondrial toxicity </p> <p>8. Aging, mitochondria, and autophagy </p> <p>9. Skin aging and mitochondria </p> <p><U>Part II - Strategies utilized to deliver natural molecules to the mitochondria</U> </p> <p>10. Organelle targeting: focus on the mitochondria </p> <p>11. Nanotechnology, mitochondria, and cancer </p> <p>12. Nanomaterials aimed towards the cardiac mitochondria: of therapeutics to nanosafety </p> <p>13. Increasing resveratrol bioavailability: a therapeutic challenge focusing on the mitochondria </p> <p>14. Advances in nanotechnology-related strategies against melanoma</p> <p>15. Challenges in the delivery of polyphenols to cancer cells </p> <p>16. Challenges in the nanoscale delivery systems development in the pharmaceutical and nutraceutical markets </p> <p>17. Therapeutic implications of targeting antioxidants to the mitochondria </p> <p>18. Nanomedicines and phytochemicals targeting Alzheimer’s Disease</p> <p>19. Mitochondria-targeted drugs and immune function </p> <p>20. Polymeric Drug Delivery Systems for Mitigating Oxidative Stress</p> <p>21. Polyphenols and the Microbiota: A Challenge in Mitochondrial Therapy</p>